Funded Startups in Or Yehuda
Seven funded companies are listed for Or Yehuda across rounds from 2021-04-12 (Memic Innovative Surgery, Series D, $96M) through 2026-05-14 (Urologic Healt…
Seven funded companies are listed for Or Yehuda across rounds from 2021-04-12 (Memic Innovative Surgery, Series D, $96M) through 2026-05-14 (Urologic Health, Seed, $11M). Disclosed amounts are led by Memic’s $96M, which dwarfs the next-largest disclosed rounds of $23M (Restore Medical, 2025-07-07) and $18M (CORDIO Medical, 2022-06-27), while the smallest disclosed amount shown is $1M (Synchrony Medical, 2026-01-12). Sector-wise, Biotechnology appears in 3 of 7 entries (Restore Medical; Append Medical; Memic Innovative Surgery), and Health Care appears in 3 of 7 (Urologic Health; Synchrony Medical; VeinWay), with one “Other” entry (CORDIO Medical). Stage labels cluster around traditional rounds—Seed/Series A/Series B/Series D are each represented once—while 2 of 7 entries are not amount-disclosed as “undisclosed” (VeinWay) or “Series Unknown” (Synchrony Medical, CORDIO Medical), indicating incomplete categorization. Time-wise, three rounds fall in a tight 2025–2026 window (Synchrony Medical 2026-01-12, Urologic Health 2026-05-14, Restore Medical 2025-07-07), suggesting recent activity concentrated near the top of the date range.
Most recent rounds
7 shownRelated listings
Frequently asked
Which disclosed round is the outlier in Or Yehuda, and how far ahead is it of the rest?
Memic Innovative Surgery’s $96M round (Series D, dated 2021-04-12) is the clear outlier; the next-largest disclosed amounts are $23M for Restore Medical (Series B, 2025-07-07) and $18M for CORDIO Medical (Venture - Series Unknown, 2022-06-27). The $1M Synchrony Medical round (Series Unknown, 2026-01-12) sits at the low end among disclosed amounts.
Do the most recent rounds cluster into a narrow date window?
Yes. Three of the seven listed rounds are in 2025–2026: Restore Medical on 2025-07-07 ($23M), Synchrony Medical on 2026-01-12 ($1M), and Urologic Health on 2026-05-14 ($11M). The remaining four are dated 2023-09-08, 2023-07-06, 2022-06-27, and 2021-04-12.
Are any sectors over-represented in this Or Yehuda set?
Biotechnology and Health Care each account for 3 of 7 entries: Biotechnology for Restore Medical (2025-07-07, $23M), Append Medical (2023-07-06, $4M), and Memic Innovative Surgery (2021-04-12, $96M); Health Care for Urologic Health (2026-05-14, $11M), Synchrony Medical (2026-01-12, $1M), and VeinWay (2023-09-08, undisclosed). CORDIO Medical is the only “Other” entry (2022-06-27, $18M).
How complete are the stage labels and disclosed amounts?
Two entries are flagged as “Series Unknown” (Synchrony Medical on 2026-01-12 for $1M, and CORDIO Medical on 2022-06-27 for $18M). One entry has an amount marked “undisclosed” (VeinWay on 2023-09-08), leaving six entries with disclosed dollar amounts for size comparisons.
Which stages appear among the disclosed set, and what does that imply about mix?
Among the labeled rounds, Seed (Urologic Health, 2026-05-14, $11M), Series A (Append Medical, 2023-07-06, $4M; VeinWay, 2023-09-08, undisclosed), Series B (Restore Medical, 2025-07-07, $23M), and Series D (Memic Innovative Surgery, 2021-04-12, $96M) each appear once. This produces a sparse stage mix, with additional categorization gaps from “Series Unknown” entries (Synchrony Medical and CORDIO Medical).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.